StockData
GE HealthCare Technologies Inc. logo

GE HealthCare Technologies Inc. (GEHC) company profile

GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 15/3011% below fair value
$83.66+1.82 (+2.22%)

Close on Nov 18, 2026Market cap $37.83BP/E 17.6Yield 0.17%

About GE HealthCare Technologies

X-Ray Apparatus & Tubes & Related Irradiation Apparatus, SIC 3844

GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital healthcare solutions provider. The company develops and distributes diagnostic imaging systems, patient monitoring devices, ultrasound systems, surgical visualization tools, life support equipment, consumable clinical accessories, and contrast agents. It organizes its business operations into four core segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Alongside physical equipment and pharmaceuticals, the enterprise delivers artificial intelligence tools, cloud platforms, workflow software, and maintenance services. Its client base includes public and private hospitals, integrated health systems, research organizations, academic centers, and government institutions.

The enterprise maintains a global commercial footprint across more than 160 countries. Its international infrastructure includes manufacturing, assembly, and pharmaceutical production operations situated across 44 facilities in 17 countries. The company employs roughly 54,000 colleagues globally, including specialized workforces of approximately 9,700 sales representatives, 8,900 field service engineers, and 11,100 research scientists and engineers. GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Summary of the business section of GE HealthCare Technologies's latest annual report, written by StockData.

Company profile

Company

Legal name
GE HealthCare Technologies Inc.
Founded
2004
Headquarters
Chicago, IL
Address
500 West Monroe Street 60661
Phone
(833) 735-1139
Employees
54,000, Dec 31, 2025
Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Chicago, Illinois

Stock & identifiers

Ticker
GEHC
Exchange
Nasdaq
IPO date
Dec 15, 2022
Shares outstanding
452M, Oct 21, 2026
Public float
$34.00B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1932393
CUSIP
36266G107
ISIN
US36266G1076
FIGI
BBG01BFR8YV1
Share class FIGI
BBG01BFR8YW0
LEI
549300OI9J7XOWZMUN85
EIN
88-2515116

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Peter J. ArduiniPresident and CEO, Director241,606
William K. GroganChief Financial Officer75,096
Adam Y. HoltonChief People Officer19,533
Taha Kass-HoutChief Technology Officer88,467
Philip RackliffeCEO, AIS41,533
George A. NewcombChief Accounting Officer10,527
Frank R. JimenezGC & Corporate Secretary89,321
Catherine EstrampesChief Commer. & Growth Officer23,573
Kevin Michael O'NeillCEO, PDx32,085
Jeannette BankesCEO, Patient Care Solutions37,293
James SaccaroChief Financial Officer87,471
Roland RottCEO, Imaging41,082
Kenneth R. StacherskiChief Enterprise Oper. Officer40,996
Thomas J. WestrickCEO, Patient Care Solutions18,501
Kevin LoboDirector14,363
Rodney F. HochmanDirector21,504
H. Lawrence Culp JrDirector499,917
Watkin Phoebe L. YangDirector13,702
Catherine A. LesjakDirector12,702
William J. StrombergDirector18,916
Anne T. MaddenDirector19,479
Tomislav MihaljevicDirector9,116
Lloyd Howell JrDirector9,116
Risa J. Lavizzo-MoureyDirector10,157

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$18.56M$19.55M$5.69M$136$122
FY2024$19.49M$13.41M$5.18M$130$114
FY2023$24.51M$29.85M$9.13M$128$101
FY2022$10.50M$7.34M$4.71M––

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsIncentive payOtherTotalvs. prior year
Peter J. Arduini
President and CEO
$1.32M$0$11.25M$3.62M$2.08M$282.22K$18.56M-5%
James Saccaro
VP and CFO
$890.42K$0$3.03M$974.98K$909.00K$93.23K$5.89M+4%
Taha Kass-Hout
Chief Science and Technology Officer
$897.12K$3.25K$3.10M$999.98K$909.00K$93.22K$6.01M+5%
Frank Jimenez
General Counsel and Corporate Secretary
$890.42K$0$2.72M$874.98K$909.00K$108.31K$5.50M+2%
Jeannette Bankes
President and CEO, Patient Care Solutions
$439.94K$160.00K$3.72M$499.98K$363.92K$171.80K$5.36M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“We are a purpose-driven global workforce of approximately 54,000 colleagues with an average tenure that reflects a strong, engaged culture.”

Corporate history

Events identified from SEC filings

DateEventDetails
Apr 25, 2023MergerRegistration of securities for a merger or exchange offer (S-4)
Dec 14, 2022Name changeName changed from GE Healthcare Holding LLC to GE HealthCare Technologies Inc.
Oct 11, 2022Spin-offRegistration as a new public company (Form 10), e.g. spin-off

See a number that looks wrong?